| Rivastigmine | RIVASTIGMINE | Zydus Lifesciences Limited | 966d59ea-5cea-4fef-8b96-e0efe885caf4 | 2025-11-17 | | Exact identifier unii: PKI06M3IW0 |
| Rivastigmine | RIVASTIGMINE | Northstar Rx LLC. | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 2025-11-14 | Warnings, Adverse reactions | Exact identifier unii: PKI06M3IW0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 8d8823c0-9339-4ec8-8a19-d13974b6614b | 2025-04-01 | Warnings, Adverse reactions | Exact identifier application number: ANDA209063 unii: PKI06M3IW0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | a7f9328e-b6da-4474-ac93-3cdd4825e163 | 2025-04-01 | Warnings, Adverse reactions | Exact identifier application number: ANDA209063 unii: PKI06M3IW0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 5cd5c434-ffd0-4aed-9eba-145c86b115bb | 2025-03-27 | Warnings, Adverse reactions | Exact identifier application number: ANDA209063 unii: PKI06M3IW0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | a68d70c9-19f2-47db-bf78-4da04a87a702 | 2025-03-20 | Warnings, Adverse reactions | Exact identifier application number: ANDA209063 unii: PKI06M3IW0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 6cc286d9-c5d4-4505-83bb-9015e3077851 | 2025-03-19 | Warnings, Adverse reactions | Exact identifier application number: ANDA209063 unii: PKI06M3IW0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Breckenridge Pharmaceutical, Inc. | b201fe68-b5e5-4a6f-8cf1-069543f03e76 | 2025-01-15 | Warnings, Adverse reactions | Exact identifier application number: ANDA209063 unii: PKI06M3IW0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 1ebeb8ec-5348-4bb1-ab3d-834690351094 | 2024-12-24 | Warnings, Adverse reactions | Exact identifier application number: ANDA209063 unii: PKI06M3IW0 |
| 254e169e-7036-f5c4-e063-6294a90a31c4 | | | 9a250350-9e85-b152-e053-2a95a90ab97d | 2024-10-25 | Warnings, Adverse reactions | Exact identifier spl id: 254e169e-7036-f5c4-e063-6294a90a31c4 spl set id: 9a250350-9e85-b152-e053-2a95a90ab97d |
| Rivastigmine | RIVASTIGMINE | Mylan Pharmaceuticals Inc. | 4ab335d1-19ee-4cd9-9776-8086645d19e4 | 2024-09-21 | Warnings, Adverse reactions | Exact identifier unii: PKI06M3IW0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 82630f84-fb47-47ab-8ee2-1720a486de02 | 2024-08-19 | Warnings, Adverse reactions | Exact identifier application number: ANDA209063 unii: PKI06M3IW0 |
| Rivastigmine | RIVASTIGMINE | Amneal Pharmaceuticals LLC | 8b671fc9-8cb0-4406-a9ee-7c95086d6200 | 2024-07-02 | Warnings, Adverse reactions | Exact identifier unii: PKI06M3IW0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | c569f760-f311-42ba-909c-a36319622b35 | 2024-05-30 | Warnings, Adverse reactions | Exact identifier application number: ANDA209063 unii: PKI06M3IW0 |
| Rivastigmine | RIVASTIGMINE | Zydus Pharmaceuticals USA Inc. | 64dad603-2389-456b-8c18-d1d40b7e7419 | 2024-05-27 | Warnings, Adverse reactions | Exact identifier unii: PKI06M3IW0 |
| Rivastigmine | RIVASTIGMINE | Sandoz Inc | 92a58ebb-748d-49f4-bf11-ecbcf5424152 | 2024-05-08 | Warnings, Adverse reactions | Exact identifier unii: PKI06M3IW0 |
| Exelon | RIVASTIGMINE | Novartis Pharmaceuticals Corporation | 07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0 | 2024-05-08 | Warnings, Adverse reactions | Exact identifier unii: PKI06M3IW0 |
| Exelon | RIVASTIGMINE | Sandoz Inc | b6ed6d15-116d-4596-92ce-3414574d7ba0 | 2024-05-08 | Warnings, Adverse reactions | Exact identifier unii: PKI06M3IW0 |